We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Aera Therapeutics Stock

Invest in or calculate the value of your shares in Aera Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

Aera Therapeutics Stock (AEAT)

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

About Aera Therapeutics Stock

Founded

2021

Headquarters

Boston, MA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of genetic medicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.

Aera Therapeutics Press Mentions

Stay in the know about the latest news on Aera Therapeutics

Aera Therapeutics Management

Leadership team at Aera Therapeutics

Board Member

Akin Akinc

Board Member

Robert Nelsen

Locked Features

Join now and verify your accreditation status to gain access to:

  • Aera Therapeutics current valuation
  • Aera Therapeutics stock price
  • Available deals in Aera Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Aera Therapeutics Stock

How to invest in Aera Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like Aera Therapeutics through EquityZen funds. These investments are made available by existing Aera Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Aera Therapeutics stock?

Shareholders can sell their Aera Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."